Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.31 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10819415 | 1.00 | TYR (0.35) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL85734 | 1.00 | TYR (0.35) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL10164725 | 1.00 | TYR (0.35) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL18090329 | 1.00 | TYR (0.35) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL85733 | 1.00 | TYR (0.35) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL20625202 | 0.99 | ALOX5 (0.36) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL10819416 | 0.99 | ALOX5 (0.36) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL85811 | 0.97 | TYR (0.35) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL15724622 | 0.96 | ALOX5 (0.36) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL15724615 | 0.96 | ALOX5 (0.36) | TYRMEN1TP53CYP3A4ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8222073-B2 | Fabricating TFT having fluorocarbon-containing layer | XEROX CORPORATION (US) | 2012-07-17 | — | — | US | disclosed |
| US-8129497-B2 | Organic thin film transistor | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8003435-B2 | Method of manufacturing organic film transistor | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-08-23 | — | — | US | disclosed |
| US-7834199-B2 | Small molecular thiophene compound having divalent linkage | XEROX CORPORATION (US) | 2010-11-16 | — | — | US | disclosed |
| US-7816263-B2 | Method for manufacturing thin film transistor | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-10-19 | — | — | US | disclosed |
| US-20100178727-A1 | METHOD OF MANUFACTURING ORGANIC FILM TRANSISTOR | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-07-15 | — | — | US | disclosed |
| US-20100105161-A1 | Method for Manufacturing Thin Film Transistor | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-04-29 | — | — | US | disclosed |
| US-7700787-B2 | Small molecular thiophene compound | XEROX CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| US-20100090199-A1 | Organic Semiconductor Film Forming Method, Organic Semiconductor Film and Organic Thin Film Transistor | KONICA MINOLTA HOLDINGS ,INC. (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20090114908-A1 | ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC THIN FILM TRANSISTOR AND METHOD OF MANUFACTURING ORGANIC THIN FILM TRANSISTOR | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-05-07 | — | — | US | disclosed |
| US-20090111210-A1 | Method for Organic Semiconductor Material Thin-Film Formation and Process for Producing Organic Thin Film Transistor | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20080108833-A1 | SMALL MOLECULAR THIOPHENE COMPOUND | XEROX CORPORATION (US) | 2008-05-08 | — | — | US | disclosed |
| US-20080108834-A1 | SMALL MOLECULAR THIOPHENE COMPOUND HAVING DIVALENT LINKAGE | XEROX CORPORATION (US) | 2008-05-08 | — | — | US | disclosed |
| US-20080048181-A1 | Organic Semiconductor Thin Film, Organic Semiconductor Device, Organic Thin Film Transistor and Organic Electronic Luminescence Element | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-02-28 | — | — | US | disclosed |
| US-7312469-B2 | Device with small molecular thiophene compound | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-20070275501-A1 | FABRICATING TFT HAVING FLUOROCARBON-CONTAINING LAYER | XEROX CORPORATION (US) | 2007-11-29 | — | — | US | disclosed |
| US-7294850-B2 | Device with small molecular thiophene compound having divalent linkage | XEROX CORPORATION (US) | 2007-11-13 | — | — | US | disclosed |
| US-20070243658-A1 | Production method of crystalline organic semiconductor thin film, organic semiconductor thin film, electronic device, and thin film transistor | KONICA MINOLTA HOLDINGS, INC. (JP) | 2007-10-18 | — | — | US | disclosed |
| US-7282735-B2 | TFT having a fluorocarbon-containing layer | XEROX CORPORATION (US) | 2007-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108834-A1 | SMALL MOLECULAR THIOPHENE COMPOUND HAVING DIVALENT LINKAGE | TST, AS3MT, TH | TYR 74/4885MEN1 2096/4885TP53 1156/4885 |
| US-20080108833-A1 | SMALL MOLECULAR THIOPHENE COMPOUND | TST, ABCG2, TPMT | TYR 338/4885MEN1 2605/4885TP53 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.